1. Home
  2. GNTA vs MLSS Comparison

GNTA vs MLSS Comparison

Compare GNTA & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genenta Science S.p.A.

GNTA

Genenta Science S.p.A.

HOLD

Current Price

$0.72

Market Cap

19.9M

Sector

Health Care

ML Signal

HOLD

Logo Milestone Scientific Inc.

MLSS

Milestone Scientific Inc.

HOLD

Current Price

$0.33

Market Cap

22.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNTA
MLSS
Founded
2014
1989
Country
Italy
United States
Employees
13
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.9M
22.1M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
GNTA
MLSS
Price
$0.72
$0.33
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
38.1K
1.3M
Earning Date
03-24-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$8,973,982.00
Revenue This Year
N/A
$12.64
Revenue Next Year
N/A
$8.99
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.99
52 Week Low
$0.59
$0.22
52 Week High
$10.00
$1.07

Technical Indicators

Market Signals
Indicator
GNTA
MLSS
Relative Strength Index (RSI) 49.00 60.23
Support Level $0.71 $0.24
Resistance Level $0.75 $0.40
Average True Range (ATR) 0.06 0.03
MACD 0.01 0.00
Stochastic Oscillator 65.56 89.50

Price Performance

Historical Comparison
GNTA
MLSS

About GNTA Genenta Science S.p.A.

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

About MLSS Milestone Scientific Inc.

Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.

Share on Social Networks: